In the case of ACC 22, sequencing not only confirmed MYB-NFIB variant 2 but also showed the additional robust presence of a MYB exon 16-NFIB exon 12 fusion transcript confirming the expression of at least one additional MYB fusion variant in this tumour (Additional file 3: Figure S2). Here, MYB is linked to neoplasm.